EU medicine regulators are planning to produce catalogs of real-world data (RWD) sources and observational studies later this year or in early 2023, and are preparing to select partners who have access to such data.
The move is part of efforts to improve the transparency of observational study data and data sources and to make it easier to judge the “evidentiary value” of observational studies...